Literature DB >> 20141674

The 2010 NCCN clinical practice guidelines in oncology on prostate cancer.

James L Mohler.   

Abstract

Entities:  

Mesh：

Year:  2010        PMID： 20141674     DOI： 10.6004/jnccn.2010.0010

Source DB:  PubMed          Journal:  J Natl Compr Canc Netw        ISSN： 1540-1405            Impact factor:   11.908


× No keyword cloud information.
  68 in total

Review 1.  Evolution of advanced technologies in prostate cancer radiotherapy.

Authors:  Nicholas G Zaorsky; Amy S Harrison; Edouard J Trabulsi; Leonard G Gomella; Timothy N Showalter; Mark D Hurwitz; Adam P Dicker; Robert B Den
Journal:  Nat Rev Urol       Date:  2013-09-10       Impact factor: 14.432

Review 2.  Integrating primary care providers in the care of cancer survivors: gaps in evidence and future opportunities.

Authors:  Larissa Nekhlyudov; Denalee M O'malley; Shawna V Hudson
Journal:  Lancet Oncol       Date:  2017-01       Impact factor: 41.316

Review 3.  Predicting Life Expectancy in Men Diagnosed with Prostate Cancer.

Authors:  Jesse D Sammon; Firas Abdollah; Anthony D'Amico; Matthew Gettman; Alexander Haese; Nazareno Suardi; Andrew Vickers; Quoc-Dien Trinh
Journal:  Eur Urol       Date:  2015-03-26       Impact factor: 20.096

4.  Gleason score 6 adenocarcinoma: should it be labeled as cancer?

Authors:  H Ballentine Carter; Alan W Partin; Patrick C Walsh; Bruce J Trock; Robert W Veltri; William G Nelson; Donald S Coffey; Eric A Singer; Jonathan I Epstein
Journal:  J Clin Oncol       Date:  2012-10-01       Impact factor: 44.544

5.  The relationship between clinical benefit and receipt of curative therapy for prostate cancer.

Authors:  Ann C Raldow; Carolyn J Presley; James B Yu; Richa Sharma; Laura D Cramer; Pamela R Soulos; Jessica B Long; Danil V Makarov; Cary P Gross
Journal:  Arch Intern Med       Date:  2012-02-27

6.  Toward ethically responsible choice architecture in prostate cancer treatment decision-making.

Authors:  J S Blumenthal-Barby; Denise Lee; Robert J Volk
Journal:  CA Cancer J Clin       Date:  2015-05-21       Impact factor: 508.702

7.  Consensus statement with recommendations on active surveillance inclusion criteria and definition of progression in men with localized prostate cancer: the critical role of the pathologist.

Authors:  Rodolfo Montironi; Elizabeth H Hammond; Daniel W Lin; John L Gore; John R Srigley; Hema Samaratunga; Lars Egevad; Mark A Rubin; John Nacey; Laurence Klotz; Howard Sandler; Anthony L Zietman; Stuart Holden; Peter A Humphrey; Andrew J Evans; Brett Delahunt; Jesse K McKenney; Daniel Berney; Thomas M Wheeler; Arul Chinnaiyan; Lawrence True; Beatrice Knudsen; Jonathan I Epstein; Mahul B Amin
Journal:  Virchows Arch       Date:  2014-10-16       Impact factor: 4.064

8.  Pelvic lymph node dissection for patients with elevated risk of lymph node invasion during radical prostatectomy: comparison of open, laparoscopic and robot-assisted procedures.

Authors:  Jonathan L Silberstein; Andrew J Vickers; Nicholas E Power; Raul O Parra; Jonathan A Coleman; Rodrigo Pinochet; Karim A Touijer; Peter T Scardino; James A Eastham; Vincent P Laudone
Journal:  J Endourol       Date:  2011-11-08       Impact factor: 2.942

Review 9.  Updated trends in imaging use in men diagnosed with prostate cancer.

Authors:  S P Porten; A Smith; A Y Odisho; M S Litwin; C S Saigal; P R Carroll; M R Cooperberg
Journal:  Prostate Cancer Prostatic Dis       Date:  2014-05-13       Impact factor: 5.554

10.  Aspirin improves outcome in high risk prostate cancer patients treated with radiation therapy.

Authors:  Corbin D Jacobs; Stephen G Chun; Jingsheng Yan; Xian-Jin Xie; David A Pistenmaa; Raquibul Hannan; Yair Lotan; Claus G Roehrborn; Kevin S Choe; D W Nathan Kim
Journal:  Cancer Biol Ther       Date:  2014-03-21       Impact factor: 4.742
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.